Skip Navigation
  Print Page

Neonatal Encephalopathy and Hypoxic Ischemic Encephalopathy: Advancing the Science and Improving Outcomes

Skip sharing on social media links
Share this:

May 8-9, 2013

Sponsor/Co-Sponsor(s)

Pregnancy and Perinatology Branch (PPB), Division of Extramural Research (DER), NICHD; Cerebral Palsy Alliance Research Foundation, Balnaves Foundation

Location

Building 31, Wing C, 6th Floor, Room 7, Bethesda, Maryland

Purpose

Neonatal encephalopathy occurs in 1 to 2 out of 1,000 births and can have devastating consequences and significant mortality. Progress has resulted from the advent of cooling techniques to treat encephalopathy, but there is continued need to refine therapies to reduce mortality and improve neurodevelopmental and medical outcomes.

The meeting will gather national and international experts in the field as well as junior investigators whose emerging careers are in an area relevant to neonatal encephalopathy and cerebral palsy (CP). Participants will:

  • Review and develop standard definitions and data collection tools to facilitate research and clinical applications.
  • Develop a research agenda for new studies in areas of scientific need for encephalopathy and CP.
  • Develop a multi-disciplinary approach to encephalopathy and CP.

Participation in this conference is by invitation only.

Contact

Dr. Rosemary Higgins, PPB, DER, NICHD
Phone: (301) 435-7909
Email: rh298n@nih.gov

Last Updated Date: 05/03/2013
Last Reviewed Date: 05/03/2013
Vision National Institutes of Health Home BOND National Institues of Health Home Home Storz Lab: Section on Environmental Gene Regulation Home Machner Lab: Unit on Microbial Pathogenesis Home Division of Intramural Population Health Research Home Bonifacino Lab: Section on Intracellular Protein Trafficking Home Lilly Lab: Section on Gamete Development Home Lippincott-Schwartz Lab: Section on Organelle Biology